1. APSMI Activities in 2021
11th Board of Directors Meeting
  The 11th Board of Directors Meeting was held on-line on Friday October 29th, 2021 under chairpersonship of Dr. Noppadon Adjimatera, TSMIA.

The Board approved the financial statements regarding 2020, confirmed the estimated account for 2021, and discussed the budget for 2021. The Secretariat reported the APSMI activities regarding its information exchange among the members as well as APSMI Newsletters. The Board decided to draft APSMI 3-year Strategic Plan.

G.P. Farmasi (Indonesia), JFSMI (Japan), and TPMMA (Chinese Taipei) reported to the Board their country/region’s hot topics regarding self-medication. The topics included requirements for registering OTC drugs, Rx-to-OTC switch, tax incentives to enhance use of OTC drugs, and telemedicine and the role of OTC drugs therein.
 
 
2. Announcement
12th APSMI Board of Directors Meeting
  The 12th APSMI Board of Directors Meeting will be held in 2022 in Thailand.
 
 
3. APSMI Activities in the past
10th Board of Directors Meeting
  The 10th Board of Directors Meeting was held on-line on Thursday October 29th, under chairpersonship of Dr. Kaijing Yan, CNMA.
The Board approved the financial statements regarding 2018 and 2019, as well as the budget for 2020. The Secretariat reported the Board that though the pandemic has been considerably limiting its activities, APSMI has initiated publishing APSMI Newsletter and strengthened Microsoft Teams-based information exchange among the members. The Board approved continuation of the efforts.
The Board confirmed the result of the Chairperson election, which had taken place in October, and agreed the Chair-Elect, Dr. Noppadon Adjimatera (TSMIA) becoming the Chairperson at the close of the 10th Board of Directors Meeting. The Board also re-elected three Vice Chairs, Mr. Rachmadi Joesoef (G.P. Farmasi), Mr. Seiichi Sato (JFSMI), and Ms. Sylvia Tsai (TMPPA) and re-appointed Dr. Toshiyoshi Tominaga as Secretary-General. The term of the officers is 2 years.
G.P. Farmasi (Indonesia), JFSMI (Japan), TSMIA (Thailand) and TPMMA (Chinese Taipei) reported to the Board their country/region’s hot topics regarding self-medication. The topics included Rx-to-OTC switch, OTC regulation update, examples of regulatory flexibilities shown under the pandemic, and promotion of OTC drugs in collaboration with the regulators and healthcare professionals, inter alia, pharmacists.